Lv6
2513 积分 2021-04-09 加入
Pembrolizumab plus chemotherapy versus chemotherapy alone for first-line treatment of advanced oesophageal cancer (KEYNOTE-590): a randomised, placebo-controlled, phase 3 study
11天前
已完结
Efficacy and Safety of Neoadjuvant Chemoimmunotherapy in Resectable Esophageal Squamous Cell Carcinoma: A Meta-analysis
11天前
已完结
Changes in CT-derived muscle mass and density during prehabilitation in patients undergoing NACT ahead of esophagectomy
12天前
已完结
Prognostic Impact of the Loss of Skeletal Muscle Mass During Neoadjuvant Chemotherapy on Older Patients with Esophageal Cancer
12天前
已完结
Impact of Skeletal Muscle Loss and Sarcopenia on Outcomes of Locally Advanced Esophageal Cancer during Neoadjuvant Chemoradiation
12天前
已完结
Surgical and Survival Benefits of Neoadjuvant Targeted Therapy versus Chemoimmunotherapy in Lung Adenocarcinoma: A Dual-center Research
15天前
已完结
Impact of Lymphatic and Venous Invasion Patterns on Postoperative Prognosis and Distant Metastasis in Esophageal Squamous Cell Carcinoma After Preoperative Chemotherapy
1个月前
已完结
Postoperative chemotherapy versus surgery alone in esophageal squamous cell carcinoma: A single-center propensity-matched survival analysis
1个月前
已完结
Postoperative chemotherapy versus surgery alone in esophageal squamous cell carcinoma: A single-center propensity-matched survival analysis
1个月前
已关闭
Surgical Outcomes of Robotic, Minimally Invasive, and Open Esophagectomy After Neoadjuvant Therapy: a Propensity Score-Matching Study
1个月前
已关闭
皖公网安备34019202002308
